"Designing Growth Strategies is in our DNA"

Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI102173

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. New Product Launches, by Key Market Players
    2. Prevalence by Disease Indication, By Key Countries/ Region, 2018
    3. Incidence of Cancer, By Key Countries/ Key Region,2018
    4. Key industry Developments - Mergers, Acquisitions and Partnerships
    5. Overview of Biomarkers In Personalized Medicine
  5. Global Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals and Specialty Clinics
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Abbott
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Thermo Fisher Scientific
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bio-Rad Laboratories, Inc
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. CENTOGENE N.V.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Axon Medchem
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Sino Biological Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. R&D System
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. BioVision Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Myriad RBM
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendation
Read Less

Figure 1:  Global Biomarkers Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Biomarkers Market Value Share (%), by Indication 2018 & 2026

Figure 3:  Global Biomarkers Market Forecast (US$ Mn), by Oncology, 2015-2026

Figure 4:  Global Biomarkers Market Forecast (US$ Mn), by Cardiology, 2015-2026

Figure 5:  Global Biomarkers Market Forecast (US$ Mn), by Neurology, 2015-2026

Figure 6:  Global Biomarkers Market Forecast (US$ Mn), by Others, 2015-2026

Figure 7:  Global Biomarkers Market Value Share (%), by End User, 2018 & 2026

Figure 8:  Global Biomarkers Market Forecast (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2015-2026

Figure 9:  Global Biomarkers Market Forecast (US$ Mn), by Diagnostics and Research Laboratories, 2015-2026

Figure 10:  Global Biomarkers Market Forecast (US$ Mn), by Hospitals and Specialty Clinics, 2015-2026

Figure 11:  Global Biomarkers Market Forecast (US$ Mn), by Others, 2015-2026

Figure 12:  Global Biomarkers Market Value (US$ Mn), by Region, 2018 & 2026

Figure 13:  North America Biomarkers Market Value (US$ Mn), by Indication, 2018 & 2026

Figure 14:  North America Biomarkers Market Value Share (%), by Indication, 2018

Figure 15:  North America Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 16:  North America Biomarkers Market Value Share (%), by End User, 2018

Figure 17:  North America Biomarkers Market Value (US$ Mn), By Country, 2018 & 2026

Figure 18:  North America Biomarkers Market Value Share (%), By Country, 2018

Figure 19:  Europe Biomarkers Market Value (US$ Mn), by Indication, 2018 & 2026

Figure 20:  Europe Biomarkers Market Value Share (%), by Indication, 2018

Figure 21:  Europe Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 22:  Europe Biomarkers Market Value Share (%), by End User, 2018

Figure 23:  Europe Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 24:  Europe Biomarkers Market Value Share (%), By Country/ Sub-region, 2018

Figure 25:  Asia Pacific Biomarkers Market Value (US$ Mn), by Indication, 2018 & 2026

Figure 26:  Asia Pacific Biomarkers Market Value Share (%), by Indication, 2018

Figure 27:  Asia Pacific Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 28:  Asia Pacific Biomarkers Market Value Share (%), by End User, 2018

Figure 29:  Asia Pacific Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 30:  Asia Pacific Biomarkers Market Value Share (%), By Country/ Sub-region, 2018

Figure 31:  Latin America Biomarkers Market Value (US$ Mn), by Indication, 2018 & 2026

Figure 32:  Latin America Biomarkers Market Value Share (%), by Indication, 2018

Figure 33:  Latin America Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 34:  Latin America Biomarkers Market Value Share (%), by End User, 2018

Figure 35:  Latin America Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 36:  Latin America Biomarkers Market Value Share (%), By Country/ Sub-region, 2018

Figure 37:  Middle East & Africa Biomarkers Market Value (US$ Mn), by Indication, 2018 & 2026

Figure 38:  Middle East & Africa Biomarkers Market Value Share (%), by Indication, 2018

Figure 39:  Middle East & Africa Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 40:  Middle East & Africa Biomarkers Market Value Share (%), by End User, 2018

Figure 41:  Middle East & Africa Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 42:  Middle East & Africa Biomarkers Market Value Share (%), By Country/ Sub-region, 2018

Figure 43:  Global Biomarkers Market Share (%), By Company, 2018

Table 1:  Global Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2015–2026

Table 2:  Global Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015–2026

Table 3:  Global Biomarkers Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 4:  North America Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2015–2026

Table 5:  North America Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 6:  North America Biomarkers Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 7:  Europe Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2015–2026

Table 8:  Europe Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 9:  Europe Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 10:  Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2015–2026

Table 11:  Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 12:  Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Latin America Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2015–2026

Table 14:  Latin America Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 15:  Latin America Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 16:  Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2015–2026

Table 17:  Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 18:  Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Biomarkers Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports